Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share (CLDX).
- Disclosed ownership: 6.7%.
- Date of event: 02 Jul 2025.
Point72 Asset Management, L.P. - 02 Jul 2025 SCHEDULE 13G Report for Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share (CLDX)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- CLDX
- Shares outstanding
- 66,632,836 shares
- Disclosed Ownership
- 4,464,400 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Jul 2025, 16:10:22 UTC
- Date of event
- 02 Jul 2025
- Next filing
- 10 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 6.7% ownership in Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share (CLDX) on 02 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Jul 2025, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 6.7% | 4,464,400 | 0 | 4,464,400 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 6.7% | 4,464,400 | 0 | 4,464,400 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 6.7% | 4,464,400 | 0 | 4,464,400 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |